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Abstract
Background: Despite a suggested link between anorexia nervosa (AN) and autism spectrum disorder (ASD),
previous studies have used self-report or diagnostic criteria to assess for ASD in AN populations, rather than
direct observation of symptom characteristic of ASD. The aim of this study was to use a standardised, clinical
assessment of ASD, the Autism Diagnostic Observation Schedule, 2nd Edition (ADOS-2), to investigate the
presence of autistic symptoms in a cross-sectional sample of women with AN.
Methods: Sixty women were recruited from inpatient or day-patient specialist eating disorder services. Each
participant underwent the ADOS-2 assessment and completed a set of self-report questionnaires assessing
eating disorder pathology and other psychiatric symptoms. IQ was also assessed.
Results: Fourteen women (23.3%) scored above clinical cutoff for ASD on the ADOS-2. Only eight of these
women displayed repetitive or restrictive behaviours, while all 14 had difficulties with social affect. Elevated
ASD symptoms were associated with increased alexithymia and obsessive-compulsive symptoms, but not
specific eating disorder pathology.
Conclusions: ASD symptoms are over-represented in women with severe AN and appear to be associated
with other psychiatric symptoms, which warrant further investigation and consideration in treatment.
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Background
Anorexia nervosa (AN) is a severe eating disorder (ED)
characterised by low body weight, restriction of energy
intake relative to requirements and undue influence of
weight and shape on self-evaluation [1]. The disorder
tends to be diagnosed during adolescence [2, 3] and
affects significantly more females than males [4, 5]. In
contrast, autism spectrum disorder (ASD) is a develop-
mental disorder defined by difficulties with social inter-
action, communication and repetitive and restricted
behaviours (RRBs) [1]. ASD affects approximately 1% of
the population, 0.2% of whom are female [6]. It is con-
sidered a heterogenic, dimensional disorder with the
identification of subgroups, based on the presence of co-
occurring psychiatric, medical and/or genetic risk of con-
tinuing importance to research and clinical practice [7].
While both ASD and AN are rare disorders in the gen-
eral population, ASD appears to be over-represented
within ED populations, with a systematic review report-
ing a mean prevalence of 22.9% [8]. Much of the re-
search on ASD in AN has come from a Swedish cohort
who was assessed for ASD at regular intervals over a
16-year period [9]. In each of the four assessments, the
diagnostic tools used to assess ASD differed, yielding
differing rates of ASD diagnosis. This underlines the
difficulty of assessing for ASD in AN, particularly in
light of evolving diagnostic criteria and the presence of
a distinct female autism phenotype [10], which makes
accurately assessing the disorder in females challenging
[11]. There is also a possibility that the acute, starved
state associated with AN may exacerbate the presence
of symptoms characteristic of ASD [12]. This state ver-
sus trait argument [12] has led to calls for further re-
search to disentangle the complex relationship between
AN and ASD.
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One of the criticisms of research examining the pres-
ence of ASD in AN is the use of inconsistent screening
tools and varying diagnostic criteria [8, 13], instead of
‘gold-standard’ clinical assessment. More recently, stud-
ies in younger people, utilising parental-report methods
[14, 15], have reported the prevalence rate of ASD to be
substantially lower than in adult studies. While this is
consistent with the idea that AN may exacerbate the
presence of ASD symptoms, diagnostic tools which rely
on parental report rather than direct observations of
autistic behaviour may result in under-reporting of ASD,
particularly in a predominantly female sample, in which
ASD may not be recognised.
Females with ASD display less RRBs than their male
counterparts and may be able to mask their social diffi-
culties, leading to under-recognition or missed diagnoses
[16, 17]. The high likelihood that ASD will remain un-
detected in females [18] can cause stress and anxiety
and may lead to the high proportion of females with
ASD whom experience co-morbid mental health difficul-
ties [17, 19]. This applies not only to ASD but also to ele-
vated symptoms of autism, which extend throughout the
population [20]. Thus, the presence of ASD symptoms
may act as a risk factor for a range of emotional and be-
haviour issues [21], including eating problems. It stands to
reason that females with elevated ASD symptoms may be
vulnerable to the development of secondary mental health
problems and are thus likely to be over-represented in ED
populations. Alternatively, the gender bias in diagnosis
may result in females with ASD being mislabelled as hav-
ing an ED, particularly as features of AN such as extreme
rigidity in eating or obsession with exercise may mask the
presence of ASD [13, 22].
Despite ASD presenting differently in females, gender-
specific diagnostic tools and criteria are yet to be widely
implemented [23]. As such, the diagnosis of adults with
ASD relies on standardised assessment tools including
the Autism Diagnostic Observation Schedule, 2nd
Edition (ADOS-2; [24]) which is yet to be tested with
women with AN. In a small-scale feasibility study [13],
the ADOS-2 was used with a pre-selected sample of
women with AN who presented with social and flexibil-
ity difficulties. Of ten women assessed, half received an
ADOS-2 ASD classification. This study demonstrated
the feasibility of using the ADOS-2 with women with
AN. However, as the study used a small sample, pre-
selected for having a suspected ASD, the high prevalence
of observed autistic difficulties cannot be generalised to
the wider AN population.
The ADOS-2 has been criticised for not showing ad-
equate specificity and sensitivity to discriminate adults
with comorbidities and no previous diagnosis of ASD
[16, 25], leading to the use of alternative measures such
as the Ritvo Autism Asperger Diagnostic Scale, Revised
(RAADS-R; [26]), with people with EDs [27]. Using the
RAADS-R, 33% of participants were classified as hav-
ing elevated ASD traits. However, the RAADS-R relies
on self-report whereas the recommended diagnosis of
ASD in adults should incorporate both self-report and
observational measures [28]. While observational mea-
sures should not be used in isolation and may not be
necessary for a diagnosis of ASD to be given [29], the
ADOS-2 is nevertheless a widely used measure of ASD
symptoms. Studies utilising this tool in AN populations
will therefore provide a useful comparison to other
studies, such as those utilising self-report measures to
assess for ASD traits [30].
This challenge of diagnosing ASD in AN is exacer-
bated by the high level of comorbidities in EDs, which
may mediate the relationship between ASD and AN. Up
to 97% of individuals hospitalised for AN are thought
to have at least one psychiatric comorbidity [31], with
particularly high rates of depression [32] and anxiety
disorders including obsessive-compulsive disorder (OCD)
[33, 34]. The presence of such comorbidities along with
the possibility that starvation exacerbates ASD symp-
toms [35] confounds the ability to differentiate between
these disorders.
Aims
The primary aim of the current study was to examine
the presence of autistic symptoms, as measured via
direct observation using the ADOS-2, in women hospi-
talised for AN. In addition, the study aimed to explore
group differences in symptoms of eating pathology as
well as other psychiatric symptoms of depression, anxiety,
alexithymia and OCD between individuals with high, sub-
clinical and no symptoms of ASD.
Methods
Study design and participants
A cross-sectional design was used to assess the presence
of ASD symptoms within a subset of women receiving
either inpatient or day-patient treatment for AN. Partici-
pants were recruited from three specialist ED services
and had a primary diagnosis of AN according to the
Diagnostic and Statistical Manual of Mental Disorders,
5th edition eating disorder (DSM-5; [1]) made prior to
admission to the recruitment sites, although exact diag-
nostic procedures may have varied across tertiary ser-
vices. Inclusion criteria for the study were the following:
(a) aged between 18 and 55 years, (b) no diagnosed his-
tory of a neurological condition or acquired brain injury,
(c) English speaking, (d) female and (e) ability and will-
ingness to provide informed written consent to partici-
pate. A total of 60 women with an age range of 18 to 47
were recruited over 14 months. Fifty-one participants
were recruited from the same national ED service,
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constituting 68% of admissions to that service over the
recruitment period. The remaining participants were re-
cruited from another inpatient service (N = 6) or day
care (N = 3). The study was reviewed and approved by
the National Research Ethics Service (14/LO/2131)
Procedure
Each participant completed the ADOS-2, and clinical
information was obtained from patient records on
current body mass index (BMI) and illness duration,
defined as the number of years since the participant
was first diagnosed with AN. In addition, participants
were asked to complete a set of self-report question-
naires assessing for the presence of depression, anxiety,
alexithymia and obsessive compulsive symptoms. All
assessments were conducted by the first author, certi-
fied research-reliable in the administration and scoring
of the ADOS-2, and were video recorded as per proced-
ural recommendations [24].
Measures
Autism Diagnostic Observation Schedule, 2nd Edition
(ADOS-2; [24])
The ADOS-2 is the most widely used and best validated
direct observation of characteristics associated with ASD
[28]. It focuses on the domains of social interaction,
communication, play and imaginative use of materials
and takes approximately 40 min to administer. The
ADOS-2 has four modules, one of which is selected for
the participant, dependent upon their expressive lan-
guage ability. Module 4 is designed for use with verbally
fluent adolescents and adults and was used for all partici-
pants in the current study. The assessment is scored ac-
cording to a standardised system and diagnostic algorithm.
Scores from the ‘Stereotyped Behaviours and Restricted
Interests’ are not included in the diagnostic classification
as these are low-frequency behaviours which may not
present in a time-limed direct observation.
The Module 4 algorithm [36] has recently been revised
to increase comparability of Module 4 to other ADOS-2
modules and to map on to updated DSM-5 diagnostic
criteria. The new algorithm consists of two sub-scores:
Social Affect and RRBs. For the diagnostic cutoff, only
the Social Affect and the sum of the two subscales are
used. With respect to clinician ASD diagnosis, the revised
Module 4 algorithm demonstrated high sensitivity (90.5%)
and specificity (82.2%). The revised algorithm is superior
to the original in that it has greater sensitivity and better
reflects the current diagnostic criteria, particularly the
symptoms displayed by females and adults with ASD
(DSM-5) [37]. For the purposes of this study, each partici-
pant was scored using both the original and revised algo-
rithms for comparison with other published studies.
Eating Disorder Examination Questionnaire (EDE-Q; [38])
The EDE-Q is a standardised and well-validated self-
report measure of the severity of the characteristic psy-
chopathology of EDs. Respondents are asked to rate how
often they have engaged in certain eating disordered
behaviours or held eating disordered concerns over the
past 28 days. The scores result in a ‘global’ or total score
and four subscale scores: ‘eating concern’, ‘weight con-
cern’, ‘shape concern’ and ‘restraint’. The maximum glo-
bal score is 6, with higher scores indicating greater
severity. The optimal cutoff score to discriminate be-
tween females with the disorder and healthy controls is
2.5 [39]. In this study, Cronbach’s alpha was .83, indicating
good internal reliability.
Hospital Anxiety and Depression Scale (HADS; [40])
The HADS is a widely used 14-item self-rating instru-
ment for anxiety and depression in patients with both
physical and mental health problems. The maximum
possible score on either subscale (anxiety/depression) is
21 with a clinical cutoff of 10. For this study, Cronbach’s
alpha was .90.
The 20-item Toronto Alexithymia Scale (TAS-20; [41])
The TAS-20 is a validated measure of alexithymia (the
inability to label and describe emotions in the self ) with
good internal consistency and test-retest reliability. It is
a 20-item self-report measure with three subscales: dif-
ficulty describing feelings; difficulty identifying feelings
and externally orientated thinking. A clinical cutoff of
61 is indicative of high alexithymia [42]; Cronbach’s
alpha was .77 in this study, indicating acceptable in-
ternal reliability.
The Obsessive-Compulsive Inventory, Revised (OCI-R; [43])
The OCI-R is an 18-item self-report scale with a five-
point Likert scale format. It consists of six subscales:
checking, washing, obsessing, neutralising, ordering
and hoarding, yielding both a total and individual sub-
scale scores. The total score ranges from 0 to 72 with a
suggested cutoff of 21 for distinguishing patients with
OCD from non-anxious controls [43]. The OCI-R has
good to excellent internal reliability among both clinic-
ally anxious and non-anxious participants and good
test-retest reliability. For this study, Cronbach’s alpha
was .94.
Wechsler Abbreviated Scale of Intelligence—2nd Edition
(WASI-II; [44])
The WASI-II is an assessment of intelligence, suitable for
individuals aged 6–90 years old. It provides estimate of
verbal and perceptual reasoning as well as full-scale IQ.
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Statistical analysis
Presence of ASD symptoms was assessed by calculating the
percentage of participants who scored above the suggested
clinical cutoff on the original and revised diagnostic algo-
rithms of the ADOS-2. To explore clinical difficulties across
the range of autistic symptom severity, participants were
split into three groups: individuals who scored above clinical
cutoff on the ADOS-2, representing high levels of autistic
symptoms (HAS); individuals with sub-clinical autistic
symptoms (SCAS) and those who scored zero on the
ADOS-2 (NAS). The decision to split participants into these
groups, rather than to analyse ADOS-2 scores as a continu-
ous variable, reflected the non-normal distribution of
ADOS-2 scores. Specifically, this distribution showed a floor
effect of the ADOS-2 with a substantial proportion (N = 22)
of the sample scoring zero on its diagnostic algorithm.
Distribution of the clinical symptom scores was assessed
visually using Q-Q plots and statistically using the Shapiro-
Wilk test. As age, illness duration, full-scale IQ and the
scores on the EDE-Q were not normally distributed (p
< .05) across all ASD groups, Kruskal-Wallis tests were
used to analyse group differences in these scores. If signifi-
cant differences were indicated, post hoc analysis using
Mann-Whitney tests was used to determine where the dif-
ference was. To account for multiple comparisons (three
comparisons per dependent variable), the Bonferroni cor-
rection was applied so all effects are reported at a .0167
level of significance. Pearson’s r effect sizes are provided for
all significant group differences for non-parametric analysis.
One-way ANOVAs were used to explore group dif-
ferences in BMI, depression, anxiety, alexithymia and
obsessive-compulsive symptoms. For ANOVA analyses,
omega squared (ω2) effect size was calculated using the
following interpretation: small (.01), medium (.06) and
large (.14) [45]. If results of the ANOVAs were statistically
significant, Tukey’s post hoc tests were used to determine
where the differences were. As some participants did not
complete all questionnaires, i.e. out of choice or due to
missing items, the N for each measure is indicated in the
results section. All data were analysed using the statistical
package IBM SPSS version 22.00.
Results
A comparison of the sociodemographic and clinical char-
acteristics of the participant groups is displayed in Table 1.
Presence of elevated ASD symptoms
Of the 60 women assessed, 13 scored above clinical cutoff
for ASD on the ADOS-2 according to the original, stan-
dardised algorithm [46]. Applying the revised algorithm,
[36] 14 participants (23.3%) scored above cutoff. The
discrepancy between the original and revised algorithms
for this individual was due to a low score on the ‘Commu-
nication’ subscale on the original algorithm. Figure 1
shows the scoring profiles for the 14 participants who
scored above clinical cutoff on the revised algorithm.
Specific ADOS-2 profile of AN sample
Only eight women who scored above the clinical cutoff
for ASD presented with RRBs. The nature of these RRBs
are shown in Table 2. A comparison of the scores of our
AN sample with previously published Module 4 scores
are displayed in Table 3.
Relationship between ADOS-2 scores and clinical symptoms
Alexithymia
Tukey’s post hoc analysis revealed that the increase in
TAS-20 total scores from NAS to SCAS (3.08, 95% CI
(−4.7 to 10.86)) was not statistically significant, p = .610,
nor was the increase from SCAS to HAS (7.24, 95% CI
[−1.61 to 16.08], p = .129). However, there was a signifi-
cant increase in score from the NAS to the HAS group
(10.32, 95% CI [1.4 to 19.24], p = .020).
For the TAS-20 ‘difficulty describing feelings’ subscale,
the increase in scores from NAS to SCAS groups (1.81,
95% CI [−.71 to 4.33]) was not statistically significant
(p = .202), nor was the increase from SCAS to HAS groups
(2.4, 95% CI [−.46 to 5.26], p = .117). The difference in
score between the NAS and HAS groups (4.21, 95% CI
[1.32 to 7.09]) was statistically significant (p = .003).
On the ‘difficulty identifying feelings’ subscale, the in-
crease in scores from the NAS to SCAS group (1.96,
95% CI [−2.30 to 6.21]) was not significant (p = .514).
However, there were significant increases in scores be-
tween the SCAS and HAS groups (5, 95% CI [.17 to 9.83],
p = .041) and between the NAS and HAS groups (6.96,
95% CI [2.08 to 11.83], p = .003).
Obsessive-compulsive symptoms
Tukey’s post hoc analysis revealed that the only signifi-
cant increase in OCI-R scores was from the NAS to the
HAS groups (19.73, 95% CI [5.66 to 33.79], p = .004).
Discussion
This study is the first to examine the presence of observ-
able ASD symptoms in a cross-sectional sample of adult
women hospitalised for AN, using the ADOS-2. Of the 60
women assessed, 14 (23.3%) scored above clinical cutoff
on the revised algorithm, indicating the presence of clin-
ical symptoms associated with ASD. The finding is in line
with previous prevalence estimates in adults with EDs, in
particular from Huke et al.’s [8] systematic review, which
reported an estimated average prevalence rate of 22.9%.
However, the rate is higher than in studies with young
people, which have suggested only a slightly increased
prevalence of 4% [14, 15]. As these studies did not use ob-
servational measures of ASD symptoms, the results are
not directly comparable.
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Fig. 1 ADOS-2 scores for participants scoring above diagnostic cutoff (HAS group). Each bar represents the total algorithm score for each
participant, consisting of the total social affect and RRB subscale scores
Table 1 Sociodemographic and clinical comparison of HAS, SCAS and NAS groups
HAS
mean (SD)
SCAS
mean (SD)
NAS
mean (SD)
Test statistic p Effect size
Agea N = 14 N = 24 N = 22
26.5 23 22 H(2) = 1.12 .572
EDE-Qa N = 14 N = 24 N = 22
Global 4.65 4.56 3.83 H(2) = 4.13 .123
Eating concern 3.63 4.25 3.36 H(2) = 1.56 .450
Shape concern 5.5 5.5 4.44 H(2) = 2.85 .241
Weight concern 4.8 4.8 3.7 H(2) = 5.59 .061
Restraint 4.4 3.8 2.9 H(2) = 4.74 .093
ED duration (years) a N = 14 N = 24 N = 22
7.5 6.5 5 H(2) = 1.18 .555
BMI N = 14 N = 24 N = 21
15.51 (2.19) 15.8 (2.02) 14.41 (2.09) F(2,56) = 1.61 .209 ω2 = .02.
HADS depression N = 14 N = 24 N = 22
12.29 (5.01) 9.46 (4.83) 8.41 (4.27) F(2, 57) = 2.99 .058 ω2 = .06
HADS anxiety N = 14 N = 24 N = 22
15.79 (4.44) 14.42 (4.58) 11.91 (5.54) F(2,57) = 2.95 .06 ω2 = .06
TAS-20 N = 14 N = 23 N = 22
Total 69.5 (7.67) 62.26 (12.17) 59.18 (11.02) F(2,56) = 3.93 .025 ω2 = .09
Describing feelings 18.57 (2.71) 16.16 (3.12) 14.36 (4.19) F(2,56) = 6.18 .004 ω2 = .15
Identifying feelings 23 (4.80) 18 (6.67) 16.05 (5.69) F(2,56) = 6.01 .004 ω2 = .15
Externally oriented 24 (3.01) 24.91 (3.75) 25.77 (2.99) F(2,56) = 1.24 .298 ω2 = .01
OCI-R N = 12 N = 22 N = 21
41.92 (18.16) 33.41 (18.10) 22.19 (12.30) F(2,52) = 6.14 .004 ω2 = .16
WASI-II full-scale IQa N = 11 N = 22 N = 20
101 107.5 117 H(2) = 1.75 .417
Significant differences are set in italics
aMedians are displayed, analysed using the non-parametric Kruskal-Wallis test
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Using the revised diagnostic algorithm [36], all 14
women who scored above clinical cutoff displayed diffi-
culties with social affect, but notably, only eight dis-
played RRBs. While RRBs are not included in the
ADOS-2 diagnostic algorithm, they form part of the
diagnostic criteria for ASD [1]. This level of RRBs is
also lower than in adults with ASD without AN, re-
ported in one previously published study using the re-
vised algorithm [37]. The most common RRB displayed
in the HAS group was speech abnormalities associated
with ASD which includes unusual intonation, volume,
rhythm or rate. There was no evidence of sensory inter-
ests or hand mannerisms in any participant.
Females with ASD have been found to display less
RRBs than males [10], and RRBs are less common in
adults compared with younger individuals [47]. There-
fore, it may be that the women who scored above cutoff
represent the typical, under-recognised profile of ASD
often seen in high-functioning females without intellec-
tual disability [48], particularly as AN is characterised by
above average intelligence (for systematic review: [49]).
In addition, it could be that the ADOS-2 was not sensi-
tive enough to detect RRBs in females with AN. RRBs
are notoriously hard to measure using direct observa-
tion, which is why they are not included in the ADOS-2
diagnostic algorithm [24]. Therefore, they may have been
present in the participants in this study but were not
detected during assessment.
There is also a possibility that the RRBs displayed in
participants in this study are not manifestations of
ASD but are instead associated with other psychiatric
symptoms including depression or anxiety. This could
account for the flat intonation displayed by several
participants and explain why other stereotypies associ-
ated with ASD, including unusual sensory interests or
complex hand mannerisms, were not observed in any
participants. In fact, the observed difficulties with
social affect could also occur within the context of
anxiety and depressive symptoms and are thus not ne-
cessarily indicative of ASD. Delineating differential
diagnoses, overlapping symptoms and true comorbidi-
ties remains a key clinical challenge [22], not only in
the field of AN but also in the accurate diagnosis of
ASD in all clinical populations.
Despite these findings supporting the idea of an over-
lap between AN and ASD, the aetiology of these symp-
toms remains unclear. Observational measures such as
the ADOS-2 cannot determine the extent to which ASD
is truly over-represented in AN or whether the observed
symptoms, at least in some cases, represent epiphenom-
ena, secondary to the ED. In this study, elevated ASD
symptoms were not related to ED psychopathology, BMI
or illness duration. These findings appear to be contrary
to the suggestion of ASD symptoms arising from the
starved state of AN [12] as if this was the case, one
would predict a linear association between ASD symp-
toms and ED symptoms. However, other symptoms of
AN including lowest recorded BMI or the presence of
amenorrhea were not examined in this study, and future
research would benefit from examining the association
between ED severity and ASD more closely, using a lon-
gitudinal design.
Table 2 Frequency of repetitive and restricted behaviours recorded in the HAS group during the ADOS-2
RRB Frequency of behaviour in HAS group
Speech abnormalities associated with autism 7
Stereotyped/idiosyncratic use of words or phrases 3
Unusual sensory interest in play material/person 0
Excessive interest in or reference to unusual or highly specific topics or objects or repetitive behaviours 4
Hand and finger and other complex mannerisms 0
Table 3 Comparison of ADOS-2 scores with published scores from Pugliese et al. [37]
HAS Published ASD SCAS Published non-ASD
N 14 253 24 68
Original Comm. 2.92 (0.64) 3.85 (1.58)a 1.21 (1.02) 1.32 (1.34)a
Algorithm Social interaction 7.08 (1.85) 8.38 (2.63)a 2.33 (1.83) 3.09 (2.50)a
Mean (SD) Comm. + social interaction 10.0 (2.04) 11.23 (4.42) 3.54 (2.04) 5.34 (4.47)
Revised Social affect 9.93 (1.94) 9.96 (4.58) 3.46 (2.04) 4.69 (4.54)
Algorithm RRBs 1.07 (1.14) 2.76 (1.84) 0.37 (0.58) 1.24 (1.53)
Mean(SD) Social affect + RRBs 11.0 (2.42) N/R 3.83 (2.14) N/R
Individuals with AN who scored 0 on the ADOS-2 (NAS) have been excluded
N/R not reported
aFrom: Hus and Lord [36]
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This study also suggests that in AN, the presence of
elevated ASD symptoms is associated with the presence
of alexithymia and obsessive-compulsive symptoms.
While it is possible that symptoms such as these may
mediate the relationship between AN and ASD, causing
individuals to appear autistic as a secondary effect of
other symptoms, it is also possible that the presence of
ASD symptoms in females may indirectly cause add-
itional mental health problems for a range of reasons,
including the stress and anxiety caused by attempting to
mask social difficulties [22].
While disorders such as OCD are common in both
AN and ASD separately [31, 50], it may also be that the
presence of both AN and elevated ASD symptoms in-
creases the likelihood of other co-occurring psychiatric
symptoms. Individuals with both diagnosed ASD and
OCD score higher on the OCI-R than those with ASD
alone [51], and as these disorders are not mutually exclu-
sive, it may be that this pattern is the same in individuals
with AN. Additionally, both AN and ASD are associated
with increased alexithymia [52], with its presence con-
tributing to poorer treatment outcome in AN [53] and
therefore the association between ASD symptoms and
alexithymia in AN is worthy of consideration.
Psychiatric symptoms such as alexithymia may also
compound the social difficulties and isolation of individ-
uals with AN [54], thus causing them to score highly on
the ADOS-2, without having a ‘true’ ASD. While research
on the use of the ADOS-2 in complex psychiatric groups
is limited, overlap in symptoms between disorders may
lead to false-positive results using its current diagnostic al-
gorithm. A study using the ADOS and the Autism Diag-
nostic Interview, Revised (ADI-R; [55]), in children with
psychosis found that participants met criteria for ASD on
this measure despite not receiving a clinical diagnosis
from clinicians [56]. Standard diagnostic assessment
packages, such as the ADOS/ADI-R, may therefore have
limited use, particularly for clinically complex groups,
highlighting the need for robust clinical assessment.
The cross-sectional design of the current study and
the small number of participants who scored above clin-
ical cutoff for ASD limit analysis to the statistical associ-
ations between variables, preventing examination of
predictor variables or causal relationships to be made.
This is the main limitation of this study, and the under-
lying aetiology of ASD symptoms in AN remains incon-
clusive. In addition, the assessment of ASD was limited
to a single observation of symptoms. While the ADOS-2
is a highly specific and sensitive assessment tool, clinical
diagnosis of ASD is multi-model, utilising direct obser-
vation, self-report, developmental history and occupa-
tional information. Future longitudinal studies using
both the ADOS-2 and a standardised parental report
measure are needed to confirm the precise nature of the
relationship between ASD and AN. As all participants in
this study were recruited from inpatient or day-patient
services, they are likely to have more severe or complex
eating disorder pathology. Therefore, the findings may
not translate to other patient groups, such as individuals
receiving less intensive treatment. It is possible that this
specific patient group experience higher levels of comor-
bidity, and thus, future studies examining ASD symp-
toms across the spectrum of EDs are warranted.
Conclusions
This study is the first to use a gold-standard observational
assessment to examine the presence of ASD symptoms in
women with severe AN. 23.3% scored above the suggested
clinical cutoff on the ADOS-2, suggesting the presence of
elevated ASD symptoms. These symptoms appeared to be
associated with other psychiatric symptoms but not spe-
cific ED pathology. Autistic symptoms co-occur with a
range of mental health problems which warrant further
investigation and consideration in treatment.
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